The results showed a close association between risk score and CSF1R of monocytes, CCL2 of tumor-associated macrophages, CD163, VSIG4, and MS4A4A of M2 macrophages, ITGAM and CEACAM8 of neutrophils, KIR2DL3 and KIR3DL2 of natural killer cells, and HLA-DPB1, HLA-DRA, HLA-DPA1, and NRP1 of dendritic cells (Figure 5B), as well as closed associated with immune checkpoint markers such as NRP1, LAIR1, and TNFSF4 (Figure 5C). This evidence concerns the gene CD163 and neoplasm.